You have 9 free searches left this month | for more free features.

alpelisib

Showing 1 - 25 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Characterize and Manage Hyperglycemia in Patients Initiating

Recruiting
  • Metastatic Breast Cancer
  • Alpelisib
  • FreeStyle Libre 2 Continuous Glucose Monitor
  • Saint Louis Park, Minnesota
    HealthPartners Cancer Research Center
Oct 16, 2023

Lymphatic Malformations Trial (Alpelisib, Placebo)

Not yet recruiting
  • Lymphatic Malformations
  • Alpelisib
  • Placebo
  • (no location specified)
Jul 4, 2023

Lymphangioma Trial in Albuquerque (Alpelisib)

Available
  • Lymphangioma
  • Alpelisib
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Thalassery, Kerala, India
    Novartis Investigative Site
Nov 21, 2022

PIK3CA-Related Overgrowth Spectrum (PROS) Trial in Worldwide (alpelisib)

Available
  • PIK3CA-Related Overgrowth Spectrum (PROS)
  • alpelisib
  • (no location specified)
Sep 9, 2022

Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 30, 2023

HR+, HER2-, Advanced Breast Cancer Trial (alpelisib)

Available
  • HR+, HER2-, Advanced Breast Cancer
  • alpelisib
  • (no location specified)
Jul 5, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Alpelisib
  • +7 more
  • (no location specified)
Jul 28, 2023

Advanced Breast Cancer Trial in Orebro (Alpelisib, fulvestrant)

Terminated
  • Advanced Breast Cancer
  • Orebro, Sweden
  • +1 more
Nov 21, 2022

Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

Not yet recruiting
  • Breast Cancer Stage IV
  • Nice, France
  • +1 more
Nov 14, 2022

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting
  • Solid Tumors, Adult
  • +7 more
  • Alpelisib
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • (no location specified)
Aug 18, 2022

Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer Trial in

Recruiting
  • Hormone Receptor Positive Breast Carcinoma
  • +2 more
  • Alpelisib
  • +2 more
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)

Active, not recruiting
  • Breast Cancer, PI3K, Alpelisib
  • Angers, France
  • +13 more
Mar 8, 2022

Breast Cancer Trial in United States (Alpelisib, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • Alpelisib
  • Sacituzumab govitecan
  • Fairway, Kansas
  • +6 more
Apr 4, 2022

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Alpelisib
  • +3 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • Alpelisib
  • +2 more
  • Aurora, Colorado
  • +2 more
Dec 29, 2022

Solid Tumor, Stomach Cancer Trial in Seongnam-si, Seoul (Alpelisib, Paclitaxel)

Recruiting
  • Solid Tumor
  • Stomach Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Aug 21, 2021

Breast Tumors Trial in China (Alpelisib, Fulvestrant, Placebo)

Recruiting
  • Breast Neoplasms
  • Alpelisib
  • +2 more
  • Hefei, Anhui, China
  • +31 more
Dec 19, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

HR+ Advanced or Metastatic Breast Cancer Trial (alpelisib)

No longer available
  • HR+ Advanced or Metastatic Breast Cancer
  • alpelisib
  • (no location specified)
Jul 13, 2021

HNSCC Trial in United States (Tipifarnib, Alpelisib)

Recruiting
  • HNSCC
  • Duarte, California
  • +10 more
Jun 30, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022